Related Experiment Videos
[Local immunologic reactions induced by CAPD]
B Faller1, J F Marichal, P Brignon
1Service de Néphrologie-Hémodialyse, Hôpital Pasteur, Colmar.
Abstract:
During CAPD, the peritoneal cavity is submitted to situations such as the accidental bacterial contaminations and the continuous presence of dialysate, which stimulate immunological factors. The antibacterial defenses include opsonins and cells. Only IgG and fibronectin are present in the peritoneal effluent but they are diluted by the dialysate. Macrophages represent 70 to 80% of the peritoneal cells. Beside good phagocytic capacity, some may have a defective bactericidal activity. The continuous presence of dialysate leads to a chronic local inflammation. Macrophages and lymphocytes will synthesize IL-1, PGE2 and IFN-Y. These substances generate movement, attachment and proliferation of fibroblasts in the peritoneal submesothelial tissue, resulting in progressive fibrosis. This fibrosis, generally asymptomatic, may be responsible for loss of Ultrafiltration (UF) and Sclerosing Encapsulating Peritonitis (SEP).
Insights
Continuous peritoneal dialysis (CAPD) can trigger immune responses and inflammation, potentially leading to peritoneal fibrosis. This condition may cause loss of ultrafiltration and Sclerosing Encapsulating Peritonitis (SEP).
Area of Science:
- Immunology
- Nephrology
- Cell Biology
Context:
- Continuous peritoneal dialysis (CAPD) involves the peritoneal cavity, which is susceptible to bacterial contamination and dialysate presence.
- These factors stimulate immunological responses, impacting antibacterial defenses like opsonins and cells.
- Peritoneal effluent contains diluted IgG and fibronectin, with macrophages dominating peritoneal cells.
Purpose:
- To investigate the immunological and cellular mechanisms underlying peritoneal fibrosis during CAPD.
- To understand how chronic inflammation in the peritoneal cavity contributes to fibrosis and its complications.
Summary:
- CAPD stimulates peritoneal immunological factors, including macrophages with potentially defective bactericidal activity.
- Continuous dialysate presence induces chronic local inflammation, with macrophages and lymphocytes synthesizing IL-1, PGE2, and IFN-γ.
- These mediators promote fibroblast proliferation in the submesothelial tissue, leading to progressive fibrosis, loss of ultrafiltration, and Sclerosing Encapsulating Peritonitis (SEP).
Impact:
- Identifies key inflammatory mediators and cellular players in CAPD-associated peritoneal fibrosis.
- Highlights the link between chronic inflammation, fibrosis, and severe complications like SEP.
- Provides insights for potential therapeutic strategies to prevent or manage peritoneal fibrosis in CAPD patients.